Drugs News and Research

RSS

Malaria elimination and insecticide resistance: an interview with Professor Hilary Ranson, Liverpool School of Tropical Medicine

The first malaria elimination programme was in the 1950s and 1960s. Malaria was eliminated from many countries in Asia and the Americas, largely by indoor spraying with insecticide. But the campaign had very little impact in Africa and eventually resources were moved away from malaria control.

30 Oct 2013

Janssen submits Marketing Authorization Application for Ibrutinib

Janssen-Cilag International NV (Janssen) announced today it has submitted a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for ibrutinib for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia (CLL)/small lymphocytic leukemia (SLL) or relapsed or refractory mantle cell lymphoma (MCL), two forms of blood cancer.

30 Oct 2013

Federal judge blocks parts of Texas abortion law

A federal judge in Texas Monday partially blocked an abortion law there that would have required abortion doctors to have admitting privileges at nearby hospitals in order to perform the procedure -- a move that abortion rights advocates say would have shuttered nearly all the state's abortion clinics.

30 Oct 2013

REDDSTAR plenary meeting to be held in Berlin on Nov 5 and 6

'Diabetes- can stem cells help?' is a free, public event that will be held on Monday, 4 November 2013 from 19:00- 20:30 at The Ruin located within the Berlin Museum of Medical History, Charité. Diabetes and stem cell researchers from around Europe will assemble for a REDDSTAR plenary meeting hosted by Charité in Berlin on November 5 and 6th.

30 Oct 2013

Alzheimer's patients more prone to heart disease, but undergo fewer related surgeries

Persons with Alzheimer's disease suffer from ischaemic heart diseases more frequently than others, yet they undergo related procedures and surgery less frequently than persons with no diagnosed AD, according to a nation-wide register-based study carried out at the University of Eastern Finland.

30 Oct 2013

Acacia Pharma begins APD403 Phase II study to prevent chemotherapy-induced nausea & vomiting

Acacia Pharma, a pharmaceutical company specialising in the development of drugs for supportive care, announces the initiation of a Phase II study of APD403 in the prevention of chemotherapy-induced nausea & vomiting (CINV).

30 Oct 2013

Researchers develop new substance that quickly and effectively kills multi-resistant bacteria

In Europe alone, more than 25,000 people die each year from infections caused by multi-resistant bacteria. Researchers from University of Copenhagen have now developed and characterized a substance that quickly and effectively kills the virulent bacteria. The substance employs a multifunctional mechanism that reduces the risk of antibiotic resistance. The findings have recently been published in the scientific journal Chemistry & Biology.

30 Oct 2013

Study looks at the feasibility of Xpert test for TB in real-life clinical setting in southern Africa

The first randomised trial to measure the impact of the rapid Xpert MTB/RIF test for tuberculosis in a real-life clinical setting finds that it can be accurately performed by a non-specialist with minimal training, improves same-day diagnosis and time to starting treatment, and increases the number of people who start treatment after testing positive on day 1 by 50%, compared with conventional TB diagnostics.

30 Oct 2013

Researchers complete first phase of landmark study on fungal complications of TB

The first phase of a landmark study of complications of tuberculosis - the first ever carried out in Africa - has been completed by researchers at Wythenshawe Hospital and the University of Manchester working with colleagues in Uganda.

30 Oct 2013

Queen's University is lead partner in £6M global research program to develop new ways to treat CF

Queen's University Belfast is a lead partner in a new -6 million (euro) global research programme to develop new ways to treat Cystic Fibrosis.

30 Oct 2013

New study reveals striking data about misuse of painkillers and sedatives by teens, young adults

With prescription drug abuse at epidemic levels nationwide, and overdoses killing more people than auto accidents in many states, a new University of Michigan study provides striking new data about the misuse of potent prescription painkillers and sedatives by teens and young adults.

30 Oct 2013

Protective effect of estrogen in women with NASH against development of severe fibrosis

New research suggests that estrogen protects women with nonalcoholic steatohepatitis (NASH) from severe liver fibrosis. According to the study published online in Hepatology, a journal of the American Association for the Study of Liver Diseases, men are at higher risk of more severe fibrosis compared to women prior to menopause, but liver fibrosis severity is similar in men and post-menopausal women.

30 Oct 2013

First Edition: October 29, 2013

Today's headlines include previews of a Capitol Hill hearing that will feature Centers for Medicare & Medicaid Serivces Administrator Marilyn Tavenner.

29 Oct 2013

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, announced the acquisition of patents for DJ5, a novel non-TZD PPARgamma agonist with potential to retard progressive renal failure in patients with autosomal dominant polycystic kidney disease ("ADPKD').

29 Oct 2013

Researchers identify possible causes of colorectal cancer resistance to bevacizumab drug

A University of Colorado Cancer Center study published in the journal PLOS ONE shows that when colorectal cancer is targeted by the drug bevacizumab (Avastin), tumors may switch dependence from VEGF-A, which is targeted by the drug, to related growth factors in including VEGF-C, VEGF-D and placental growth factor.

29 Oct 2013

Serotonin 2C receptors induce fast-acting antidepressant effects in mice

More than 1 in 10 Americans take antidepressants, but these medications can take weeks-and for some patients, months-before they begin to alleviate symptoms. Now, scientists from the University of Chicago have discovered that selectively blocking a serotonin receptor subtype induces fast-acting antidepressant effects in mice, indicating a potential new class of therapeutics for depression. The work was published Oct. 29 in Molecular Psychiatry.

29 Oct 2013

Bending ethical norms to serve patients' interests

A survey among rheumatologists finds many face moral dilemmas when trying to do what's best for their patients in the current health care environment.

29 Oct 2013

Eisai supplies diethylcarbamazine citrate 100 mg tablets to WHO

Eisai Co., Ltd. announced today that it has begun the free supply of diethylcarbamazine citrate (DEC) 100 mg tablets produced at its Vizag Plant in India to the World Health Organization in line with its commitment to help WHO in its global effort to eliminate lymphatic filariasis in targeted developing and emerging countries.

29 Oct 2013

NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases

If you've ever been sleep-deprived, you've probably had a firsthand glimpse of the blood vessels in your eyes. But what you haven't seen—and what many eye care professionals cannot see as well as they would like—are the vessels closest to the retina, the light-sensitive tissue at the back of the eye.

29 Oct 2013

Questions about medical necessity for some surgeries, screenings

The Washington Post looks at the dramatic increase in spinal fusion surgeries and whether all are necessary, while Kaiser Health News examines screenings for stroke and heart disease, some of which are not recommended for healthy people.

29 Oct 2013

Drugs News and Research

Malaria elimination and insecticide resistance: an interview with Professor Hilary Ranson, Liverpool School of Tropical Medicine

Janssen submits Marketing Authorization Application for Ibrutinib

Federal judge blocks parts of Texas abortion law

REDDSTAR plenary meeting to be held in Berlin on Nov 5 and 6

Alzheimer's patients more prone to heart disease, but undergo fewer related surgeries

Acacia Pharma begins APD403 Phase II study to prevent chemotherapy-induced nausea & vomiting

Researchers develop new substance that quickly and effectively kills multi-resistant bacteria

Study looks at the feasibility of Xpert test for TB in real-life clinical setting in southern Africa

Researchers complete first phase of landmark study on fungal complications of TB

Queen's University is lead partner in £6M global research program to develop new ways to treat CF

New study reveals striking data about misuse of painkillers and sedatives by teens, young adults

Protective effect of estrogen in women with NASH against development of severe fibrosis

First Edition: October 29, 2013

3Sbio acquires patents for DJ5 to delay hereditary renal disease in ADPKD patients

Researchers identify possible causes of colorectal cancer resistance to bevacizumab drug

Serotonin 2C receptors induce fast-acting antidepressant effects in mice

Bending ethical norms to serve patients' interests

Eisai supplies diethylcarbamazine citrate 100 mg tablets to WHO

NEI-funded study explores methods to improve diagnosis, treatment of common eye diseases

Questions about medical necessity for some surgeries, screenings

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News